FLUORESCENCE GUIDED SURGERY SYSTEMS MARKET ANALYSIS

Fluorescence Guided Surgery Systems MarketSize and Trends

The global fluorescence guided surgery systems market was valued at US$ 67.8 Mn in 2021 and is forecast to reach a value of US$ 199.0 Mn by 2028 at a CAGR of 16.6%between 2022 and 2028. The fluorescence guided surgery systems market is experiencing strong growth due to the increasing prevalence of chronic disease across the globe and rise in usage of advanced imaging techniques. Moreover, increasing number of surgical procedures for target diseases is expected to boost growth of the market. However, factors such as stringent regulatory approval, side effects associated with fluoroscopy, and lack of skilled professionals expected to hamper growth of the global fluorescence guided surgery systems market.

Global Fluorescence Guided Surgery Systems Market Trends:

FGS is an imaging technique that helps surgeon to visualise different structures and types of tissues during a surgical procedure that may not be visible under white light conditions. Further advances and developments in fluorescence guided surgery systems are expected to eventually replace older methods of detecting structures and types of tissues during surgical procedures. This in turn is expected to propel growth of the market, and this trend is expected to continue during the forecast period.

Compared to conventional medical imaging techniques such as Magnetic Resonance Imaging (MRI) and Computed Tomography (CT), FGS can provide real-time imaging during surgery, and it is much cheaper and much easier to operate. Therefore, the use of fluorescence guided surgery (FGS) systems has increased worldwide, and this trend is expected to continue during the forecast period, driving the growth of the market.